Directed West Coast sales division, which included over 75 Territory Managers and 7 Pain Territory Managers. Spearheaded network management; built robust relationships with targeted/non-targeted pharmacists, physicians, and administrators. Identified new business opportunities and remained knowledgeable about market/products/clients/geographies to pursue prospects efficiently. Formulated contracts for pharmacies/wholesalers and created procedures for territory sales department aligned with regulatory standards and DEA regulations. Maintained communication with C-level executives to understand resource constraints and resolve issues appropriately. Coached and mentored sales teams on tailored strategies to ensure optimum productivity.• Advanced business development through strategic marketing, coherent staff training, and innovative product features to amplify provider utilization.• Procured new Direct Purchase accounts, which became the fastest growing product portfolio.• Generated sales team growth of 600% from 2015 to 2019 through detailed training and mentorship.• Boosted sales by 100% each year consistently

Managed portfolios for urology, cardiovascular, endocrine, pain, and various others. Developed and opened new accounts through the utilization of consultative sales methods. Cultivated new business opportunities and strengthen existing client relationships. Implemented process improvements, introduced product solutions, and produced appropriate application methods to return the most effective results. Trained healthcare professionals on medication use. Crafted business plans; detailed local/regional/national market forces which impacted sales.• Awarded as Presidents Club Winner in 2015.• Gained promotion to Mist Pharmaceuticals through a consistent display of hard work and diligence.• Accomplished top portfolio national sales for 2015 with over $1M in sales.• Delivered exceptional work and gained rank as 1st in the nation out of 112 representatives (2015).• Amplified business growth and exceeded sales targets by 23%